Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal

Impact · against what's priced in

MASI shares are expected to surge toward $180 following Danaher's all-cash acquisition offer at a 38% premium. The event is a primary catalyst for MASI, while the impact on DHR remains neutral as a strategic capital deployment.

MASI+1.00

No priced-in read yet

In context

The offer to acquire Masimo at $180 per share represents a 38% premium over the previous close, creating a direct path for the share price to converge with the offer price.

Read from the article alone

• healthcare
• m and a
• MASI
• acquisition
• cash deal
• medical devices

Search tags